MeSH tree: D20.215.894.899.050
Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans.
Oct 30, 2024
0
115
One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.
Sep 20, 2024
0
94
Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.
Sep 2, 2024
0
67
A study by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) at CUNY SPH, published in the journal AIDS and Behavior, found that gay and bisexual men reported a general willingness ...
Aug 19, 2024
0
77
Researchers at Stanford Engineering have developed a nanoparticle platform that could make existing vaccines more effective, including those for influenza, COVID-19, and HIV. In addition to helping vaccine candidates produce ...
Aug 7, 2024
0
86
Nearly 40 million people were living with the HIV virus that causes AIDS last year, over 9 million weren't getting any treatment, and the result was that every minute someone died of AIDS-related causes, the U.N. said in ...
Jul 23, 2024
0
58
An Oregon Health & Science University-developed platform for cytomegalovirus-based vaccines shows promise as a "shield" against cancer. The findings were recently published in the journal Science Advances.
May 29, 2024
0
91
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
May 17, 2024
0
160
A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.
May 9, 2024
0
84
The path to a successful HIV vaccine depends on a critical first step—activating specific immune cells that induce broadly neutralizing antibodies.
Jan 5, 2024
0
150
